Form 4 for NEO NEOGENOMICS INC
Accepted 2021-12-30 00:00:00 ET · period of report 2021-12-30 · accession 0001077183-21-000278 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-30 | 2021-12-30 | NEO | Mallon Mark | CEO, Dir | A - Grant | $0.00 | +152.9K | 225.6K | +210% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-30 | A | A | 152,858 | $0.00 | 225,594 | D | — | — |